Reaction Details Report a problem with these data
Target
D(3) dopamine receptor
Ligand
BDBM476838
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
0.077±n/a nM
Citation
 Tobinaga, H; Masuda, K; Inagaki, M; Yonehara, M; Masuda, M Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect US Patent  US10870660 Publication Date 12/22/2020 
Target
Name:
D(3) dopamine receptor
Synonyms:
DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3
Type:
n/a
Mol. Mass.:
44243.43
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
400
Sequence:
MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM476838
Synonyms:
US10870660, Compound III-610 | US11345716, Compound III-610
Type:
Small organic molecule
Emp. Form.:
C26H31F3N4O3S
Mol. Mass.:
536.61
SMILES:
CN1Cc2c(cccc2C(=O)N[C@H]2CC[C@H](CCN3CCc4sc(OCC(F)(F)F)nc4C3)CC2)C1=O |r,wU:15.16,wD:12.12,(11.85,-1.67,;11.08,-.33,;9.55,-.17,;9.23,1.33,;10.57,2.1,;10.57,3.64,;9.23,4.41,;7.9,3.64,;7.9,2.1,;6.56,1.33,;6.56,-.21,;5.23,2.1,;3.9,1.33,;2.56,2.1,;1.23,1.33,;1.23,-.21,;-.1,-.98,;-1.44,-.21,;-2.77,-.98,;-2.77,-2.52,;-4.1,-3.29,;-5.44,-2.52,;-6.9,-2.99,;-7.81,-1.75,;-9.35,-1.75,;-10.12,-3.08,;-11.66,-3.08,;-12.43,-4.41,;-13.2,-3.08,;-12.43,-1.75,;-6.9,-.5,;-5.44,-.98,;-4.1,-.21,;2.56,-.98,;3.9,-.21,;11.71,1.07,;13.2,1.47,)|
Structure:
Search PDB for entries with ligand similarity: